Empagliflozin Induces Vascular Relaxation in Rat Coronary Artery Due to Activation of BK Channels
Qi Kong,Ling-ling Qian,Lei Zhang,Huan-huan Liu,Fan Yang,Xiao-lu Zhang,Chao Wang,Xiao-xi Zhao,Ku-lin Li,Ru-xing Wang
DOI: https://doi.org/10.2147/dmso.s419125
2024-01-20
Diabetes Metabolic Syndrome and Obesity Targets and Therapy
Abstract:Qi Kong, 1 Ling-ling Qian, 1 Lei Zhang, 1 Huan-huan Liu, 1, 2 Fan Yang, 1 Xiao-lu Zhang, 1 Chao Wang, 1 Xiao-xi Zhao, 1 Ku-lin Li, 1 Ru-xing Wang 1, 2 1 Department of Cardiology, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi People's Hospital, Wuxi Medical Center, Nanjing Medical University, Wuxi, 214023, People's Republic of China; 2 Wuxi School of Medicine, Jiangnan University, Wuxi, 214122, People's Republic of China Correspondence: Ru-xing Wang; Ku-lin Li, Department of Cardiology, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi People's Hospital, Wuxi Medical Center, Nanjing Medical University, Wuxi, 214023, People's Republic of China, Email ; Purpose: The aim of this study was to investigate the effects and mechanisms of SGLT2 inhibitor empagliflozin on diabetic coronary function. Methods: A rat diabetic model was established by injection of streptozotocin. Rats in the treated group were administered empagliflozin by gavage and rat coronary vascular tensions were measured after eight weeks. Large conductance calcium activated K + channel currents were recorded using a patch clamp technique, while human coronary artery smooth muscle cells were used to explore the underlying mechanisms. Results: After incubation with empagliflozin (10, 30, 100, 300, 1000 μmol/L), the Δ relaxation % of rat coronary arteries were 2.459 ± 1.304, 3.251 ± 1.119, 6.946 ± 3.407, 28.36 ± 11.47, 86.90 ± 3.868, respectively. Without and with empagliflozin in the bath solution, BK channel opening probabilities at a membrane potential of +60 mV were 0.0458 ± 0.0517 and 0.3413 ± 0.2047, respectively ( p < 0.05, n = 4 cells). After incubation with iberiotoxin, the Δ tensions of rat coronary arteries in the control (Ctrl), untreated (DM), low empagliflozin (10 mg/kg/d)-treated (DM+L-EMPA) and high empagliflozin (30mg/kg/d)-treated (DM+H-EMPA) group were 103.20 ± 5.85, 40.37 ± 22.12, 99.47 ± 28.51, 78.06 ± 40.98, respectively ( p < 0.01 vs Ctrl, n = 3– 7; p < 0.001 vs DM+L-EMPA, n = 5– 7). Empagliflozin restored high glucose-induced downregulation of Sirt1, Nrf2, and BK-β 1, while the effect of empagliflozin disappeared in the presence of EX-527, a Sirt1 selective inhibitor. Conclusion: Empagliflozin has a vasodilation effect on the coronary arteries in a concentration-dependent manner and can activate BK channels via the Sirt1-Nrf2 mechanism. Keywords: diabetes, SGLT2 inhibitor, vasodilatation, large conductance calcium activated potassium channel Diabetes mellitus (DM), as a chronic non-communicable disease, seriously harms human health. According to the World Health Organization, more than 3 million people worldwide die from diabetes mellitus and related complications each year, mainly from cardiovascular disease (CVD), especially with the most severe coronary vascular lesions. 1 Therefore, exploring the pathogenesis of diabetic coronary function and improving diabetic cardiovascular lesions are of great significance. Sodium-glucose co-transporter-2 (SGLT2) inhibitors are oral hypoglycemic drugs that reduce blood glucose level by inhibiting glucose re-absorption in the renal tubules. Representative drugs of this kind include empagliflozin (EMPA), canagliflozin, dapagliflozin, etc. In addition to glucose control, SGLT2 inhibitors have a wide range of cardiovascular benefits, including improving cardiac energy supply, reducing arterial stiffness, and inhibiting cardiac remodeling effects. 2–4 Recent studies have demonstrated that SGLT2 inhibitor is of great significance in vasodilation, independently of its hypoglycemic effect, which may be associated with K + channels on vascular smooth muscle cells (SMCs). 5,6 Large conductance calcium activated K + (BK) channel consists of four α subunits and four β subunits, 7 widely distributed in all tissues and cells of the human body, especially in vascular SMCs, and is one of the main K + channels on coronary artery SMCs. 8 Our previous study showed that, 9 BK channels regulate coronary artery relaxation, and BK channel function is impaired in diabetes mellitus. In this study, we aimed to examine the vasodilation of empagliflozin and the effect of empagliflozin on BK channels, exploring new mechanisms of the cardiovascular protection of SGLT2 inhibitors and providing a new clinical strategy for the management of cardiovascular complications in diabetes mellitus. Male Sprague Dawley (SD) rats (weight 180 ± 20g) were purchased from Changzhou Carvens Laboratory Animal Co., Ltd. in China. -Abstract Truncated-
endocrinology & metabolism